Ajanta Pharma reports a 6% fall in Q4 consolidated net profit

Ajanta Pharma has reported results for the fourth quarter and year ended March 31, 2019.

The company has reported a fall of 47.30% in its net profit at Rs 41.37 crore for the quarter under review as compared to Rs 78.50 crore for the same quarter in the previous year. Total income of the company decreased by 11.07% at Rs 416.72 crore for Q4FY19 as compared Rs 468.60 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 5.93% in its net profit at Rs 88.89 crore for the quarter under review as compared to Rs 94.49 crore for the same quarter in the previous year. Total income of the company decreased by 3.50% at Rs 516.79 crore for Q4FY19 as compared Rs 535.55 crore for the corresponding quarter previous year.

For the year ended March 31, 2019, the company has reported a fall of 8.36% in its net profit at Rs 391.76 crore as compared to Rs 427.52 crore for the previous year. Total income of the company decreased by 1.51% at Rs 1,874.77 crore for year under review as compared to Rs 1,903.46 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has reported a fall of 17.43% in its net profit at Rs 386.97 crore as compared to Rs 468.64 crore for the previous year. Total income of the company decreased by 3.65% at Rs 2,076.45 crore for year under review as compared to Rs 2,155.02 crore for year ended March 31, 2018.

Best services products with best technical support which will make your Financial Trading easy let us know, you more click here for the next level >> Stock Cash Trading Tips

Please follow and like us:
20